HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Familial Acute Myeloid Leukemia with Mutated Cebpa

Also Known As:

Cebpa-Dependent Familial Acute Myeloid Leukemia; Familial Acute Myeloid Leukaemia

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Neoplasms: 1324753
- Neoplasms by Histologic Type: 2
  - Leukemia: 58722
    - Myeloid Leukemia: 4026
      - Acute Myeloid Leukemia: 26405
        Familial Acute Myeloid Leukemia with Mutated Cebpa: 1
Hemic and Lymphatic Diseases: 6
- Hematologic Diseases: 3366
  - Leukemia: 58722
    - Myeloid Leukemia: 4026
      - Acute Myeloid Leukemia: 26405
        Familial Acute Myeloid Leukemia with Mutated Cebpa: 1

Related Diseases

1.	Neoplasms (Cancer)
2.	GATA2 Deficiency

Experts

1.	Benyó, Gábor: 1 article (02/2016)
2.	Bödör, Csaba: 1 article (02/2016)
3.	Csomor, Judit: 1 article (02/2016)
4.	Király, Péter Attila: 1 article (02/2016)
5.	Kállay, Krisztián: 1 article (02/2016)
6.	Marosvári, Dóra: 1 article (02/2016)
7.	Szőke, Anita: 1 article (02/2016)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Familial Acute Myeloid Leukemia with Mutated Cebpa:

1.	telomerase RNA (bTR)IBA 02/21/2016 - "Currently, four recognized syndromes could be separated: familial acute myeloid leukemia with mutated CEBPA, familial myelodysplastic syndrome/acute myeloid leukemia with mutated GATA2, familial platelet disorder with propensity to myeloid malignancy with RUNX1 mutations, and telomere biology disorders due to mutations of TERC or TERT. "